The European Nuclear medicine Market was valued at US$X.XX billion in 2016 and is projected to expand at a CAGR of XX.XX% over the forecast period to reach US$X.XX billion by 2022. This research study examines the nuclear medicine market on the basis of various segments. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to the demand, supply, and sales, in addition to the recent developments, have been provided in this report. The report also analyzes key players in the nuclear medicine market. The report provides comprehensive forecast up to the period 2022 for various key segments, with 2016 as base year.
The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical segments. Moreover, the research study analyzes the overall regulatory framework of the European nuclear medicine market, offering stakeholders a better understanding of the key factors affecting the overall market environment.
The first step towards determining the nuclear medicine market size involves identifying key players and the revenue contribution of the overall business or relevant segment aligned to the study in consideration through extensive secondary research. This also includes various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others. Both bottom-up and top down approaches are utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the nuclear medicine value chain, who are C-Level Executives, Directors, and Managers among others across key enterprises operating as manufacturers, suppliers, and distributors. The last phase is providing intelligence in the form of presentation, charts, graphics and other different formats helping the clients in faster and efficient understanding of the market. Under this phase complete market engineering is involved which includes analyzing the gathered data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Segments covered under the nuclear medicine market report are as below:
Central Nervous System
By End-User Industry
Key industry players profiled as part of this section are BRACCO PHARMA, Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Fujifilm Holdings Corporation, GE Healthcare (Subsidiary of General Electric Company), Nordion, Inc., and Taiyo Nippon Sanso Corporation among few others.
The report’s target audience is as below:
Cambridge Isotope Laboratories, Inc.
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary of General Electric Company)
Taiyo Nippon Sanso Corporation
Lantheus Medical Imaging, Inc.
Koninklijke Philips N.V
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.